Healthline: Controversial studies find COVID-19 may be far more widespread than previously known
UC expert says lack of testing could be a factor
Healthline interviewed Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases for a news story on two studies in California finding that COVID-19 may be much more widespread than previously thought.
Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases. Photo/Colleen Kelley/UC Creative + Brand
Fichtenbaum said one of the reasons for the discrepancy was a lack of testing.
“Because testing for the virus is not widely available due to lack of supplies, reagents, and machines, it’s not surprising that a sero-epidemiologic survey would find more individuals with infection,” Fichtenbaum said.
Read the entire article here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
German TV highlights UC expert's ancient Maya discoveries
March 2, 2026
The German television show 'Unsolved Case' talks to a University of Cincinnati expert about ballcourts used by the ancient Maya for a program examining how people used spheres as both tools and toys.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment
February 26, 2026
The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.